Debra Messner
Family · Huntingdon, PANPI 1447407929
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 182 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 182 payments — averaging $17.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$513
- AbbVie$387
- GSK$347
- Novo Nordisk$329
- Pfizer$253
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$252
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,19599%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 32 | $513 |
| AbbVie | 19 | $387 |
| GSK | 24 | $347 |
| Novo Nordisk | 19 | $329 |
| Pfizer | 12 | $253 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 12 | $252 |
| AstraZeneca | 10 | $164 |
| Otsuka America Pharmaceutical, Inc. | 9 | $162 |
| Exact Sciences | 8 | $150 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $103 |
| Johnson & Johnson | 4 | $89 |
| Merck | 5 | $83 |
| Boehringer Ingelheim | 3 | $62 |
| Astellas Pharma US Inc | 3 | $59 |
| Xeris Pharmaceuticals, Inc. | 2 | $48 |
| Phathom Pharmaceuticals, Inc. | 4 | $47 |
| Nevro Corp. | 1 | $46 |
| Sanofi Pasteur Inc. | 2 | $31 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $30 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| Indivior Inc. | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Abbott | 1 | $13 |
| Amgen | 1 | $12 |
How this compares
$3,242 in reported general payments places this provider in the 90th percentile of 4,717 family providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 43 | $55,658 |
| TrulicityDulaglutide | 39 | $52,995 |
| JardianceEmpagliflozin | 47 | $48,636 |
| EliquisApixaban | 51 | $38,311 |
| OzempicSemaglutide | 32 | $34,649 |
| MounjaroTirzepatide | 25 | $32,863 |
| JanuviaSitagliptin Phosphate | 30 | $22,032 |
| RybelsusSemaglutide | 17 | $19,123 |
| NucyntaTapentadol Hcl | 12 | $14,994 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $8,564 |
| XareltoRivaroxaban | 14 | $8,299 |
| Rosuvastatin Calcium | 138 | $3,161 |
| Sucralfate | 18 | $2,924 |
| Levothyroxine Sodium | 168 | $2,485 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $2,123 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $513 | $85,85764 claims |
| AstraZenecaFarxiga | $164 | $55,65843 claims |
| Novo NordiskOzempic, Rybelsus | $329 | $53,77249 claims |
| Boehringer IngelheimJardiance | $62 | $48,63647 claims |
| PfizerEliquis | $253 | $38,31151 claims |
| MerckJanuvia | $83 | $22,03230 claims |
| GSKTrelegy Ellipta | $347 | $8,56412 claims |
| Johnson & JohnsonXarelto | $89 | $8,29914 claims |
| AbbVieSynthroid | $387 | $1,71219 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,717 family providers in Pennsylvania.
Other family in Huntingdon
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Stephanie HarshbargerCamp Hill$317K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
- Margaret RosenzweigPittsburgh$89K
- Amanda GrippoDickson Cty$86K
- Patricia HabdasPittsburgh$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.